The U.S. study reveals that one in three patients with COVID-19 develops brain disease

Researchers from Chicago found that frequent neurological and enceplopalysia are associated with the disease of coronary patients.

A study by Northwestern Medicine in Chicago has found that almost one in three hospital - accepted coronary patients develop encephalopati, which means damage or disease affecting brain function or structure.

In the U.S., which tops the list of the most affected Coronavirus nations more than 415,000 people are hospitalised with COVID-19, according to the COVID Tracking Project.

After the study was published this week, it has raised serious national concerns after highlighting the facts about mental damage caused by COVID-19.

Ensephalopiasia may be caused by infectious agents such as bacteria, virus, or prion metabolic or mitocondrial failure, brain tumor, or pressure added to the skull.

Prolonged exposure to toxic elements, including drugs, colors, industrial chemicals, radiation and metals, chronic progressive trauma, poor food or lack of oxygen or the flow of blood into the brain can also cause such medical conditions.

The symptoms are:

Confusion

Memory Loss

Personal Changes

The Problem of Clear Thinking or Focusing

Talking Problem

The weakness of muscles or shocks that cannot be controlled

Eyes That Cannot Control

Dripping

A Problem With Drowning

Sleep

Loss of Smell

Igor Coralnik, professor of neurology at Northwestern University, has treated several patients infected with coronarys in Northwestern Medical Health care.

The expert, who is one of the authors of the study, said that “encephalopiasia, which is characterized by the changed mental function from slight confusion in a coma, is the most serious neurological display of COVID-19”.

The study, which was published in Clinical Neurology Analies, was conducted in 509 patients infected with SARS-CoV-2 within the hospital network in Chicago and its suburbs.

Researchers explored the neurological manifestations of coronary - induced disease and noted its presence at 82.3 percent of patients with COVIED-19 at some point in the disease.

According to the study, most frequent neurological manifestations include-

Mialgia, or muscle pain, (44.8 percent of all who have been considered)

Headache (37.7 percent)

Encepfalopati (31.8 percent)

Attention (29.7 percent)

Modified taste (15.9 percent)

Loss of smell (11.4 percent)